Biweekly cetuximab and irinotecan as third-line therapy in patients with advanced colorectal cancer after failure to irinotecan, oxaliplatin and 5-fluorouracil (Q46748546)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Biweekly cetuximab and irinotecan as third-line therapy in patients with advanced colorectal cancer after failure to irinotecan, oxaliplatin and 5-fluorouracil |
scientific article |
Statements
1 reference
Biweekly cetuximab and irinotecan as third-line therapy in patients with advanced colorectal cancer after failure to irinotecan, oxaliplatin and 5-fluorouracil (English)
1 reference
B Jensen
1 reference
P Pfeiffer
1 reference
D Nielsen
1 reference
J Bjerregaard
1 reference
C Qvortrup
1 reference
M Yilmaz
1 reference
14 February 2008
1 reference
1 reference
19
1 reference
1141-1145
1 reference
6
1 reference
Identifiers
1 reference
1 reference